Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Prasco Laboratories is set to market and distribute Shionogi's Nitrofurantoin Oral Suspension - a therapeutically equivalent and substitutable for the brand Furadantin Oral Suspension.
Subscribe to our email newsletter
Prasco plans to start shipping Nitrofurantoin Oral Suspension immediately in the US under the Prasco label.
Nitrofurantoin is used to treat urinary tract infections.
Prasco CEO Thomas Arington said the company is pleased to work with Shionogi to extend another of its brands, Furadantin Oral Suspension, into their authorized generic product line as Nitrofurantoin Oral Suspension.